title: [Interleukin-6 reflects the disease severity and prognosis of myeloma].
authors.affiliation: MediCity Research aboratory, Turku University Central Hospital, Finland.
authors.forename: T T
authors.initials: TT
authors.lastname: Pelliniemi
authors.forename: K
authors.initials: K
authors.lastname: Pulkki
mesh_terms: D015415:Biomarkers / Q000097:blood*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000032:analysis*; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D015850:Interleukin-6; D019947:Receptors, Interleukin-6
vernacular_title: Interleukiini 6 myelooman ennusteen arvioinnissa.